6Weinblatt ME, Keystone EC, Furst DE, et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial [J]. Arthritis Rheum, 2003, 48 (1) : 35-45.
7Weinblatt ME, Keystone EC, Furst DE, et al. Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study [J]. Ann Rheum Dis, 2006, 65 (6) : 753-759.
8Jamal S, Patra K, Keystone EC. Adalimumab response in patients with early versus established rheumatoid arthritis: DE019 randomized controlled trial subanalysis [J]. Clin Rheumatol, 2009, 28 (4) : 413-419.
9Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment [J]. Arthritis Rheum, 2006, 54(1): 26-37.
10Burmester GR, Mariette X, Montecuceo C, et al. Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research inActive Rheumatoid Arthritis (ReAct) trial[J]. Ann Rheum Dis, 2007, 66 (6) : 732-739.
